ALKS) — Alkermes plc (NASDAQ

Marco Green
April 17, 2018

The company is estimating to achieve earnings per share (EPS) growth of 31.50% in this year and the earnings per share (EPS) growth expected to be 883.53% in the next year. The FDA refusal at the start of the month had knocked more than 20 per cent off the company's market value.

NASDAQ ALKS traded up $1.90 during trading hours on Monday, reaching $44.43. The indicator does not indicate the price direction, rather it is used primarily to measure volatility caused by gaps and limit up or down moves. SVB Financial Group (NASDAQ:SIVB) has risen 33.86% since April 16, 2017 and is uptrending.

Alkermes (NASDAQ:ALKS) last posted its quarterly earnings data on Wednesday, February 14th. Following the transaction, the insider now directly owns 73,068 shares of the company's stock, valued at approximately $4,384,080. Following the completion of the sale, the chief accounting officer now owns 16,943 shares in the company, valued at $928,645.83. The company's distance from 52-week high price is -37.12% and the current price is 8.82% away from 52-week low price.

Traders have different rules for what constitutes liquidity and a good guide is the volume of trades and volume of shares that are traded each day. It has underperformed by 11.55% the S&P500. During the same quarter in the previous year, the firm earned $0.02 earnings per share. analysts expect that Alkermes will post -0.8 EPS for the current year. Therefore 61% are positive. Alkermes had 38 analyst reports since September 1, 2015 according to SRatingsIntel. The firm has "Neutral" rating by UBS given on Thursday, October 6.

Shares of Alkermes stock opened at $58.28 on Friday. The firm has "Outperform" rating given on Thursday, January 21 by Leerink Swann. The stock has "Overweight" rating by Barclays Capital on Wednesday, July 13. Cowen & Co downgraded the shares of ALKS in report on Thursday, January 21 to "Market Perform" rating. As per Friday, October 21, the company rating was upgraded by JP Morgan.

Investors sentiment decreased to 0.75 in Q4 2017. It's down -0.29, from 1.04 in 2017Q3. Dimensional Fund Advisors LP raised its position in Alkermes by 1.0% during the third quarter. The hedge funds in our database now possess: 152.34 million shares, up from 144.69 million shares in 2017Q3. Morgan Stanley invested in 0% or 57,581 shares. Mitsubishi Ufj Tru And Corporation holds 0.03% or 308,970 shares in its portfolio. Price T Rowe Assoc Md reported 16.46M shares. Dekabank Deutsche Girozentrale has invested 0.04% in Alkermes plc (NASDAQ:ALKS). Brown Brothers Harriman And Company stated it has 0% in Alkermes plc (NASDAQ:ALKS). Toronto Dominion Bankshares accumulated 9,056 shares. First Light Asset Mngmt Ltd Liability invested in 29,533 shares. Epoch Prtn, a New York-based fund reported 121,242 shares. Macquarie Group Ltd invested 0.01% in Alkermes plc (NASDAQ:ALKS). Alkermes plc (ALKS) has declined 0.51% since April 16, 2017 and is downtrending. The stock of Alkermes plc (NASDAQ:ALKS) has "Buy" rating given on Tuesday, June 6 by Jefferies. Mitsubishi Ufj Tru & Bk invested in 308,970 shares. Creative Planning holds 0% or 18,141 shares in its portfolio.

A number of large investors have recently bought and sold shares of the stock. American Century has invested 0.09% in SVB Financial Group (NASDAQ:SIVB). State Street Corp now owns 3,745,283 shares of the company's stock valued at $208,160,000 after buying an additional 74,500 shares in the last quarter. Millennium Mgmt Limited Liability holds 27,807 shares. Asset Management One Commerce holds 0.03% or 221,743 shares in its portfolio. A consensus recommendation for an individual stock compiles ratings from a number of analysts who track that stock. Boston Prtn accumulated 0.02% or 60,035 shares. The stock has "Hold" rating by Evercore on Tuesday, August 23. Sumitomo Mitsui Holding invested 0.04% in SVB Financial Group (NASDAQ:SIVB). Commercial Bank Of Montreal Can owns 13,194 shares or 0% of their United States portfolio. Blackrock has 5.10M shares.

Since February 2, 2018, it had 0 insider buys, and 4 insider sales for $2.72 million activity. The stock has seen its SMA50 which is now -1.19%. One analyst has rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company. Oppenheimer maintained it with "Outperform" rating and $41 target in Wednesday, October 7 report. (NASDAQ:PINC) has "Buy" rating given on Monday, September 11 by Jefferies. Analyst Recommendation is an outlook of a stock-market analyst on a stock. The company was maintained on Friday, October 20 by Mizuho.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Click Lancashire

Discuss This Article